Synonym
Azapetine; Ilidar Base
IUPAC/Chemical Name
6-Allyl-6,7-dihydro-5H-dibenz(c,e)azepine
InChi Key
NYGHGTMKALXFIA-UHFFFAOYSA-N
InChi Code
InChI=1S/C17H17N/c1-2-11-18-12-14-7-3-5-9-16(14)17-10-6-4-8-15(17)13-18/h2-10H,1,11-13H2
SMILES Code
C=CCN1Cc2ccccc2c3ccccc3C1
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
235.33
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Ishida Y, Sasaki Y, Kimura Y, Watanabe K. Alpha-adrenolytic properties of apogalanthamine and azapetine analogs. J Pharmacobiodyn. 1985 Nov;8(11):917-23. doi: 10.1248/bpb1978.8.917. PMID: 2869118.
2: van Oene JC, de Vries JB, Horn AS. The effectiveness of yohimbine in blocking rat central dopamine autoreceptors in vivo. Naunyn Schmiedebergs Arch Pharmacol. 1984 Oct;327(4):304-11. doi: 10.1007/BF00506241. PMID: 6514014.
3: Minneman KP, Johnson RD. Characterization of alpha-1 adrenergic receptors linked to [3H]inositol metabolism in rat cerebral cortex. J Pharmacol Exp Ther. 1984 Aug;230(2):317-23. PMID: 6146710.
4: Martin GE, Papp NL. Blockade of MK-801 induced ipsiversive turning in 6-OHDA lesioned rats by alpha 1-adrenoceptor antagonists. Pharmacol Biochem Behav. 1984 Jun;20(6):893-7. doi: 10.1016/0091-3057(84)90014-5. PMID: 6146989.
5: Borsini F, Nowakowska E, Samanin R. Effect of repeated treatment with desipramine in the behavioral "despair" test in rats: antagonism by "atypical" but not "classical" neuroleptics or antiadrenergic drugs. Life Sci. 1984 Mar 19;34(12):1171-6. doi: 10.1016/0024-3205(84)90089-4. PMID: 6143232.
6: Boyle FC, Digges KG. Responses to catecholamines of the rat isolated uterus throughout the natural oestrous cycle. Naunyn Schmiedebergs Arch Pharmacol. 1982 Oct;321(1):56-62. doi: 10.1007/BF00586350. PMID: 6890631.
7: Reichenbacher D, Reimann W, Starke K. alpha-Adrenoceptor-mediated inhibition of noradrenaline release in rabbit brain cortex slices. Receptor properties and role of the biophase concentration of noradrenaline. Naunyn Schmiedebergs Arch Pharmacol. 1982 Apr;319(1):71-7. doi: 10.1007/BF00491481. PMID: 6125897.
8: Blakeley AG, Cunnane TC, Petersen SA. An electropharmacological analyses of the effects of some drugs on neuromuscular transmission in the vas deferens of the guinea-pig. J Auton Pharmacol. 1981 Dec;1(5):367-75. doi: 10.1111/j.1474-8673.1981.tb00075.x. PMID: 6123511.
9: King BF, Muir TC. The response of the rabbit rectococcygeus muscle to stimulation of extrinsic inhibitory nerves and to sympathomimetic drugs. Br J Pharmacol. 1981 May;73(1):87-95. doi: 10.1111/j.1476-5381.1981.tb16775.x. PMID: 7284702; PMCID: PMC2071839.
10: Hedler L, Stamm G, Weitzell R, Starke K. Functional characterization of central alpha-adrenoceptors by yohimbine diastereomers. Eur J Pharmacol. 1981 Mar 5;70(1):43-52. doi: 10.1016/0014-2999(81)90430-1. PMID: 6260514.
11: Timmermans PB, Van Meel JC, Van Zwieten PA. Evaluation of the selectivity of alpha-adrenoreceptor blocking drugs for postsynaptic alpha 1- and alpha 2-adrenoreceptors in a simple animal model. J Auton Pharmacol. 1980 Nov;1(1):53-60. doi: 10.1111/j.1474-8673.1980.tb00441.x. PMID: 6122689.
12: Hammond DL, Levy RA, Proudfit HK. Hypoalgesia following microinjection of noradrenergic antagonists in the nucleus raphe magnus. Pain. 1980 Aug;9(1):85-101. doi: 10.1016/0304-3959(80)90031-7. PMID: 7422339.
13: Tsoucaris-Kupfer D, Bogaievsky D, Schmitt H. Furter investigations on the interaction between alpha-adrenoceptor antagonists and the central hypotensive effect of clonidine in rats, rabbits and dogs. Clin Exp Pharmacol Physiol. 1980 Jul;7(4):355-66. doi: 10.1111/j.1440-1681.1980.tb00083.x. PMID: 6106536.
14: Clineschmidt BV, Flataker LM, Faison E, Holmes R. An in vivo model for investigating alpha 1- and alpha 2-receptors in the CNS: studies with mianserin. Arch Int Pharmacodyn Ther. 1979 Nov;242(1):59-76. PMID: 44455.
15: Brown CM, McGrath JC, Summers RJ. The effects of alpha-adrenoceptor agonists and antagonists on responses of transmurally stimulated prostatic and epididymal portions of the isolated vas deferens of the rat. Br J Pharmacol. 1979 Aug;66(4):553-64. doi: 10.1111/j.1476-5381.1979.tb13694.x. PMID: 37964; PMCID: PMC2043588.
16: Ruenitz PC, McLennon TP, Sternson LA. Biotransformation of azapetine to oxazapetine in rat and rabbit liver fractions. Drug Metab Dispos. 1979 Jul- Aug;7(4):204-7. PMID: 39720.
17: Singh SP, Parmar SS, Farnum SA, Stenberg VI. 13C-NMR spectra of alpha- adrenergic blocking agents. J Pharm Sci. 1979 Jul;68(7):890-2. doi: 10.1002/jps.2600680728. PMID: 37324.
18: Hwang EC, Van Woert MH. DDT-induced myoclonus: serotonin and alpha noradrenergic interaction. Res Commun Chem Pathol Pharmacol. 1979 Feb;23(2):257-66. PMID: 37558.
19: Hwang EC, van Woert MH. Serotonin-norepinephrine interactions in the tremorolytic actions of phenoxybenzamine and trazodone. Pharmacol Biochem Behav. 1979 Jan;10(1):27-9. doi: 10.1016/0091-3057(79)90164-3. PMID: 312503.
20: Qayum A, Yusuf SM. Effect of azapetine phosphate on the isolated rat ureter preparation. Life Sci. 1977 Dec 1;21(11):1617-20. doi: 10.1016/0024-3205(77)90239-9. PMID: 23477.
